Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
02/02/2010 | US7655656 crystalline 6-[[(3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxypheny)sulfonyl]-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone; industrial scale |
02/02/2010 | US7655649 Inhibitors of Akt activity |
02/02/2010 | CA2541301C P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
01/28/2010 | WO2010011684A2 Prodrug and fluoregenic compositions and methods for using the same |
01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
01/28/2010 | WO2010011538A1 Amidophenoxyindazoles useful as inhibitors of c-met |
01/28/2010 | WO2010010970A1 Coloring matter for optical information recording medium and optical information recording medium |
01/28/2010 | WO2010010933A1 Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolin-5-yl) acetamide derivative |
01/28/2010 | WO2010010058A1 Method of preparing anhydrous alfusozin hydrochloride |
01/28/2010 | WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants |
01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
01/28/2010 | US20100022778 Process for production of sulfinylbenzimidazole compounds or salts thereof |
01/28/2010 | US20100022589 Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
01/28/2010 | US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
01/28/2010 | US20100022543 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
01/28/2010 | US20100022516 4,5-Disubstituted-2-aryl pyrimidines |
01/28/2010 | US20100022484 4-Chromenonyl-1,4-dihydropyridines and their use |
01/28/2010 | CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
01/28/2010 | CA2731773A1 Amidophenoxyindazoles useful as inhibitors of c-met |
01/28/2010 | CA2728629A1 Adamantyl diamide derivatives and uses of same |
01/27/2010 | EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives |
01/27/2010 | EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
01/27/2010 | EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
01/27/2010 | EP2044051B1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
01/27/2010 | EP1656353B1 Gabanergic modulators |
01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
01/27/2010 | CN101636396A Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8 -di fluorochroman- s -yl ) -1, 3-dihydroimidazole-2-thione |
01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
01/27/2010 | CN100586244C Compound, charge transporting material and organic electroluminescent element |
01/27/2010 | CN100584891C Sulfoxides or sulfones grafted onto polymers |
01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
01/27/2010 | CN100584830C Gabanergic modulators |
01/26/2010 | US7652153 Caspase inhibitors and uses thereof |
01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
01/26/2010 | US7652040 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
01/26/2010 | US7652011 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
01/26/2010 | US7652010 Azabicyclic aryl derivatives and their medical use |
01/26/2010 | US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof |
01/26/2010 | US7651978 Selective herbicides based on a substituted phenylsulphonylaminocarbonyl-triazolinone |
01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
01/21/2010 | WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
01/21/2010 | WO2010009069A1 Chromene modulators of chemokine receptor activity |
01/21/2010 | WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
01/21/2010 | WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
01/21/2010 | WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
01/21/2010 | WO2010006755A2 A compound for imaging cell death |
01/21/2010 | WO2010006350A1 Melamine epoxides |
01/21/2010 | WO2009125430A8 Improved process for producing darifenacin |
01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
01/21/2010 | US20100016380 TNF-alpha production inhibitors |
01/21/2010 | US20100016343 Alpha7 nicotinic acetylcholine receptor inhibitors |
01/21/2010 | US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
01/21/2010 | US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
01/21/2010 | US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease |
01/21/2010 | US20100016285 Heterocyclidene-n-(aryl) acetamide derivative |
01/21/2010 | US20100016252 Mannich Base N-Oxide Drugs |
01/21/2010 | US20100016177 Templated molecules and methods for using such molecules |
01/21/2010 | US20100016154 Imaging system |
01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
01/21/2010 | CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
01/21/2010 | CA2731053A1 A compound for imaging cell death |
01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
01/21/2010 | CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
01/21/2010 | CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
01/20/2010 | EP2145886A1 Twelve-membered cyclomacrolactam derivative |
01/20/2010 | EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
01/20/2010 | EP2144898A2 Heterocyclic hydrazide compound and pesticidal use of the same |
01/20/2010 | EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
01/20/2010 | EP2144885A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
01/20/2010 | EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
01/20/2010 | EP1828148B1 Triazole substituted aminobenzophenone compounds |
01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
01/20/2010 | CN100582103C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
01/19/2010 | US7649002 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
01/19/2010 | US7649001 Fused benzene derivative and use |
01/19/2010 | US7648971 Thrombopoietin mimetics |
01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
01/19/2010 | US7648738 for photopolymerization; photography, relief imaging; color filters |